Corona Virus
Stay Safe, FollowGuidance
Fetching Location Data…
James Hyerczyk
Asia Pacific Shares

The major Asia-Pacific stock indexes finished mixed but mostly higher on Tuesday in a choppy trade as Asian stocks edged cautiously into record territory following Monday’s strong performance by the U.S. benchmarks the previous session. The markets were primarily supported by news of another promising coronavirus vaccine although the reaction was not as spectacular as last Monday’s spike to the upside.

In the cash market on Tuesday, Japan’s Nikkei 225 Index settled at 26014.62, up 107.69 or +0.42%. Hong Kong’s Hang Seng Index finished at 26394.66, up 12.99 or +0.05% and South Korea’s KOSPI Index closed at 2539.15, down 3.88 or -0.15%.


In China, the Shanghai Index settled at 3339.90, down 7.07 or -0.21% and Australia’s S&P/ASX 200 Index finished at 6498.20, up 13.90 or +0.21%.

COVID-19 Update

Outbreaks in the United States are still spiking, as the country added 1 million new cases of the virus in under a week. The country has now recorded more than 11 million COVID-19 cases, according to Johns Hopkins University data.


Vaccine Hopes Lift Markets

Asian traders followed Wall Street’s lead from Monday after the U.S. benchmarks rose to record highs after Moderna said preliminary phase three trial data shows its coronavirus vaccine is more than 94% effective in preventing COVID-19. Its shares gained 9.6% on the day.

That news came after Pfizer and BioNTech announced last week that their coronavirus vaccine was more than 90% effective.

Nikkei Hits 29-year High as Vaccine Optimism Boosts Risk Appetite

Japan’s Nikkei share average closed at a 29-year high on Tuesday as investors cheered news of another potential coronavirus vaccine that re-ignited hopes of a swift global recovery. The benchmark index had closed at a 29-year high on Monday as well after the economy posted its first expansion in four quarters.

Around two-thirds of the 33 sector sub-indexes on the Tokyo exchange traded higher. The airline sector led gains, climbing 3.96%, with ANA Holdings and Japan Airlines adding 4.16% and 3.72%, respectively.

Nikkei’s heavyweight Fanuc Corp rose nearly 1.5%, helped by upbeat industrial output data from China and the formation of a regional trade bloc comprising 15 Asia-Pacific economies.

South Korea Stocks Reverse Early Gains on Stricter Virus Curbs, Profit-Taking

South Korean shares closed lower on Tuesday, reversing earlier gains as the country tightened coronavirus-related curbs and investors booked profits after a rally in the benchmark index. The won strengthened, while the benchmark bond yield fell. The benchmark KOSPI Index hit a 33-month high on Monday, its tenth session of gains out of eleven.

South Korea decided to strengthen social distancing rules for the greater Seoul area amid spikes in coronavirus cases, as it reported 230 new infections as of Monday midnight. The stricter new curbs hit optimism fueled by Moderna Inc’s vaccine announcement.

In other news, Chip giant Samsung Electronics slipped 0.9% after hitting a record high, while its peer SK Hynix extended gains to a sixth session.

For a look at all of today’s economic events, check out our economic calendar.
Don't miss a thing!
Discover what's moving the markets. Sign up for a daily update delivered to your inbox

Trade With A Regulated Broker

  • Your capital is at risk
The content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your own due diligence checks, apply your own discretion and consult your competent advisors. The content of the website is not personally directed to you, and we does not take into account your financial situation or needs.The information contained in this website is not necessarily provided in real-time nor is it necessarily accurate. Prices provided herein may be provided by market makers and not by exchanges.Any trading or other financial decision you make shall be at your full responsibility, and you must not rely on any information provided through the website. FX Empire does not provide any warranty regarding any of the information contained in the website, and shall bear no responsibility for any trading losses you might incur as a result of using any information contained in the website.The website may include advertisements and other promotional contents, and FX Empire may receive compensation from third parties in connection with the content. FX Empire does not endorse any third party or recommends using any third party's services, and does not assume responsibility for your use of any such third party's website or services.FX Empire and its employees, officers, subsidiaries and associates, are not liable nor shall they be held liable for any loss or damage resulting from your use of the website or reliance on the information provided on this website.
This website includes information about cryptocurrencies, contracts for difference (CFDs) and other financial instruments, and about brokers, exchanges and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and come with a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money.FX Empire encourages you to perform your own research before making any investment decision, and to avoid investing in any financial instrument which you do not fully understand how it works and what are the risks involved.